{
  "stage": "S3",
  "passed": false,
  "convergence_score": 0.8344,
  "convergence_threshold": 0.85,
  "convergence_pass": false,
  "jaccard": 0.3744,
  "jaccard_threshold": 0.85,
  "jaccard_pass": false,
  "type_01_ratio": 0.8667,
  "type_01_threshold": 0.75,
  "type_pass": true,
  "cosine": 0.8344,
  "jsd": 0.2501,
  "kappa": 0.8603,
  "type_distribution": {
    "0": 0.26666666666666666,
    "1": 0.6,
    "2": 0.0,
    "3": 0.13333333333333333
  },
  "divergence_map": {
    "total_unique_claims": 15,
    "most_divergent": [
      {
        "statement": "CBD, erastin, and DIDS engage three structurally and mechanistically distinct VDAC1 sites \u2014 lipid-protein interface (CBD), interior barrel wall \u03b214-19 (erastin), and pore vestibule lysines (DIDS) \u2014 with no significant competitive overlap.",
        "models_supporting": [
          "claude"
        ],
        "types_assigned": [
          1
        ],
        "confidences": [
          0.78
        ],
        "type_variance": 0,
        "n_supporters": 1
      },
      {
        "statement": "VDAC2's 11-residue N-terminal extension sterically remodels the helix-groove pocket, reducing CBD-type ligand affinity by \u226510-fold and enabling VDAC1-selective design without relying solely on cofactor competition.",
        "models_supporting": [
          "claude"
        ],
        "types_assigned": [
          2
        ],
        "confidences": [
          0.55
        ],
        "type_variance": 0,
        "n_supporters": 1
      },
      {
        "statement": "At clinical concentrations (1\u201310 \u03bcM), CBD achieves only ~30\u201350% VDAC1 occupancy (Kd = 11 \u03bcM), producing graded gating modulation rather than channel ablation \u2014 this partial occupancy is pharmacologically essential for tolerability.",
        "models_supporting": [
          "claude"
        ],
        "types_assigned": [
          1
        ],
        "confidences": [
          0.8
        ],
        "type_variance": 0,
        "n_supporters": 1
      },
      {
        "statement": "Barrel-wall ligands (erastin class) produce near-binary conductance block (Hill coefficient \u22651.5, steep dose-response), while helix-site ligands (CBD class) produce graded allosteric modulation (Hill coefficient ~1, shallow dose-response), representing pharmacologically distinct classes.",
        "models_supporting": [
          "claude"
        ],
        "types_assigned": [
          2
        ],
        "confidences": [
          0.6
        ],
        "type_variance": 0,
        "n_supporters": 1
      },
      {
        "statement": "1**: CBD, erastin, and DIDS bind three distinct VDAC1 sites: CBD at the lipid-protein interface near the N-term helix, erastin in the barrel wall (\u03b214\u201319), and DIDS covalently at pore-facing lysines (K12/K20). *TYPE*: 1 *CONFIDENCE*: 0.85 *MECHANISM*: CBD\u2019s lipophilicity (logP 6.3) drives partitioning into membrane-adjacent grooves; erastin\u2019s sulfonamide engages polar barrel residues (E73/R15); DIDS\u2019s isothiocyanates react with solvent-accessible lysines. *FALSIFIABLE BY*: Cryo-EM showing CBD in the barrel lumen or erastin at the N-term; mutagenesis (K12A/K20A) abolishing DIDS binding without affecting erastin.",
        "models_supporting": [
          "mistral"
        ],
        "types_assigned": [
          2
        ],
        "confidences": [
          0.5
        ],
        "type_variance": 0,
        "n_supporters": 1
      },
      {
        "statement": "2**: VDAC2\u2019s +11aa N-terminal extension sterically occludes VDAC1-like CBD/erastin sites, enabling >10-fold VDAC1 selectivity at 1\u201311 \u03bcM. *TYPE*: 1 *CONFIDENCE*: 0.75 *MECHANISM*: The extended N-term in VDAC2 (unstructured/helical) shields the gating domain, reducing ligand access vs. VDAC1\u2019s compact helix. *FALSIFIABLE BY*: Chimeric VDAC1/2 constructs (VDAC1 + VDAC2 N-term) showing reduced CBD affinity; cryo-EM of VDAC2 with CBD bound.",
        "models_supporting": [
          "mistral"
        ],
        "types_assigned": [
          2
        ],
        "confidences": [
          0.5
        ],
        "type_variance": 0,
        "n_supporters": 1
      },
      {
        "statement": "3**: N-term helix ligands (e.g., CBD) act as allosteric gating modulators (EC50 ~11 \u03bcM), while barrel ligands (erastin/DIDS) act as pore blockers (Ki <1 \u03bcM). *TYPE*: 1 *CONFIDENCE*: 0.70 *MECHANISM*: Hel",
        "models_supporting": [
          "mistral"
        ],
        "types_assigned": [
          2
        ],
        "confidences": [
          0.5
        ],
        "type_variance": 0,
        "n_supporters": 1
      },
      {
        "statement": "CBD, erastin, DIDS bind distinct VDAC1 sites: CBD at lipid-facing N-helix groove (residues 1-25/\u03b21-2), erastin in barrel lumen (\u03b214-19, E73",
        "models_supporting": [
          "grok"
        ],
        "types_assigned": [
          2
        ],
        "confidences": [
          0.5
        ],
        "type_variance": 0,
        "n_supporters": 1
      },
      {
        "statement": "VDAC1 ligand binding sites define two distinct pharmacological classes: (1) N-terminal helix binders (e.g., CBD) are allosteric modulators of voltage-gating, and (2) Barrel-occluding ligands (e.g., erastin, DIDS) are direct conductance blockers.",
        "models_supporting": [
          "gemini"
        ],
        "types_assigned": [
          1
        ],
        "confidences": [
          0.9
        ],
        "type_variance": 0,
        "n_supporters": 1
      },
      {
        "statement": "The VDAC2 N-terminal extension sterically hinders the VDAC1-like CBD binding pocket, reducing CBD affinity by at least an order of magnitude (predicted VDAC2 Kd > 100 \u03bcM).",
        "models_supporting": [
          "gemini"
        ],
        "types_assigned": [
          1
        ],
        "confidences": [
          0.85
        ],
        "type_variance": 0,
        "n_supporters": 1
      }
    ],
    "models_present": [
      "claude",
      "mistral",
      "grok",
      "gemini",
      "deepseek"
    ]
  },
  "recommendation": "S3 gate FAILED. The system did not converge to stable consensus. This indicates genuine scientific disagreement worth investigating. Review the divergence map below."
}